|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 288.90 BDT | -0.48% |
|
-4.62% | -15.45% |
| Market Cap | 6.37B 51.58M 45.31M 42.13M 38.66M 72.64M 4.97B 73.76M 500M 195M 2.44B 194M 189M 8.44B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 54.03M 47.45M 44.13M 40.5M 76.09M 5.2B 77.26M 524M 205M 2.56B 203M 198M 8.84B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | -0.48% | ||
| 1 week | -4.62% | ||
| Current month | -7.70% | ||
| 1 month | -6.54% | ||
| 3 months | -10.14% | ||
| 6 months | -20.08% | ||
| Current year | -15.45% |
| 1 week | 286.8 | 299 | |
| 1 month | 285 | 314.8 | |
| Current year | 285 | 391.8 | |
| 1 year | 285 | 587.5 | |
| 3 years | 217.2 | 726.9 | |
| 5 years | 69.5 | 1,000 | |
| 10 years | 44 | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2013-12-31 | |
| Director of Finance/CFO | - | 2020-11-07 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2013-12-31 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1983-05-04 |
| Director/Board Member | 45 | 1999-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.48% | -4.62% | -14.35% | -22.86% | 47.61M | ||
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | ||
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | ||
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | ||
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | ||
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | ||
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | ||
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | ||
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | ||
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | ||
| Average | +0.39% | +0.96% | +22.14% | +44.84% | 364.36B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.7M 5.88M 5.47M 5.02M 9.43M 645M 9.58M 64.96M 25.38M 317M 25.14M 24.6M 1.1B | 665M 5.38M 4.73M 4.4M 4.03M 7.58M 518M 7.7M 52.2M 20.4M 255M 20.2M 19.77M 881M |
| Net income | 42.33M 343K 301K 280K 257K 483K 33M 490K 3.32M 1.3M 16.22M 1.29M 1.26M 56.09M | 35.02M 284K 249K 232K 212K 399K 27.3M 405K 2.75M 1.07M 13.42M 1.06M 1.04M 46.41M |
| Net Debt | 290M 2.35M 2.07M 1.92M 1.76M 3.31M 226M 3.36M 22.81M 8.91M 111M 8.83M 8.64M 385M | 302M 2.45M 2.15M 2M 1.83M 3.44M 236M 3.5M 23.72M 9.27M 116M 9.18M 8.98M 400M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | BDT 288.90 | -0.48% | 132,491 |
| 26-07-22 | BDT 290.30 | -1.06% | 177,409 |
| 26-07-21 | BDT 293.40 | +0.17% | 185,294 |
| 26-07-20 | BDT 292.90 | -0.98% | 173,596 |
| 26-07-19 | BDT 295.80 | -2.34% | 179,031 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
















